Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Japanese drugmaker sees opportunities at China import expo

STORY: Japanese drugmaker sees opportunities at China import expo SHOOTING TIME: Nov. 9, 2023 DATELINE: Nov. 10, 2023 LENGTH: 00:00:49 LOCATION: SHANGHAI, China CATEGORY: ECONOMY SHOTLIST: 1. various of Takeda's exhibits at the sixth CIIE 2. SOUNDBITE (Chinese): SHAN GUOHONG, Senior vice president of Takeda and president of Takeda China STORYLINE: Takeda Pharmaceutical, one of Japan's biggest drugmakers, is a "frequenter" at this year's China International Import Expo (CIIE) in Shanghai. Over the past six years, China has grown to be Takeda's third largest market globally. And the company's Chinese subsidiary has developed into one of the best-performing transnational pharmaceutical firms in China. SOUNDBITE (Chinese): SHAN GUOHONG, Senior vice president of Takeda and president of Takeda China "We are very pleased to be able to participate in the CIIE every year. This platform enables us to swiftly bring our global innovation achievements to China. In the future, we will continue to strengthen our coop

E

First settlement reached in hepatitis damages suits against state

FUKUOKA, Japan - A total of 29 hepatitis C sufferers suing the state and drugmakers for damages settled suits with the state in Osaka and Fukuoka on Feb. 4, the first such settlement among a series of similar lawsuits filed by about 240 people nationwide since 2002. Photo shows plaintiffs smiling during a news conference the same day after the settlement of their suit at the Fukuoka High Court.

E

Gov't, hepatitis C patients sign accord to end legal battle

TOKYO, Japan - Health, Labor and Welfare Minister Yoichi Masuzoe (L) bows before the representatives of the plaintiffs in hepatitis C damages lawsuits against the state and drugmakers, at the Health, Labor and Welfare Ministry in Tokyo on Jan. 15 after the two sides signed a basic accord to end the protracted legal battle. The agreement is based on a law enacted last week offering blanket relief to those who contracted the liver illness through contaminated blood products such as fibrinogen which were administered to stop bleeding.

E

Gov't, hepatitis C patients sign accord to end legal battle

TOKYO, Japan - Health, Labor and Welfare Minister Yoichi Masuzoe (R) shakes hands with Michiko Yamaguchi, leader of the plaintiffs in hepatitis C damages lawsuits against the state and drugmakers, at the Health, Labor and Welfare Ministry in Tokyo on Jan. 15 after the two sides signed a basic accord to end the protracted legal battle. The agreement is based on a law enacted last week offering blanket relief to those who contracted the liver illness through contaminated blood products such as fibrinogen which were administered to stop bleeding.

E

Gov't again ordered to pay damages over hepatitis C virus infection

TOKYO, Japan - Plaintiffs and their supporters express their joy on March 23 after the Tokyo District Court joined two other district courts in ordering the government to pay damages to people infected with the hepatitis C virus after being treated with tainted blood products. Presiding Judge Atsuo Nagano, acting on a 1,353 million yen damages suit, ordered the state and three drugmakers to pay a total of 259 million yen to 13 out of the 21 plaintiffs.

E

State, drugmakers ordered to compensate over hepatitis C infections

OSAKA, Japan - Tomoko Kuwata (L) and Seiko Takeda, plaintiffs in a damages suit, hold a press conference after the Osaka District Court ruled on June 21 that the state and drugmakers were responsible for nine out of 13 people who were infected with the hepatitis C virus after being treated with tainted blood products. The ordered them to pay a total 256 million yen in damages.

E

State, drugmakers ordered to compensate over hepatitis C infections

OSAKA, Japan - A man holds a ''victory banner' in front of the Osaka District Court on June 21 after the court ordered the state and drugmakers to pay a total 256 million yen in damages to nine out of 13 people who were infected with the hepatitis C virus after being treated with tainted blood products.

E

State, drugmakers ordered to compensate over hepatitis C infections

OSAKA, Japan - Plaintiffs enter the Osaka District Court on June 21 before the court ordered the state and drugmakers to pay a total 256 million yen in damages to nine out of 13 people who were infected with the hepatitis C virus after being treated with tainted blood products.

E

Drugmakers Dainippon, Sumitomo to merge in Oct. 2005

TOKYO, Japan - Dainippon Pharmaceutical Co. President Kenjiro Miyatake (L) and Sumitomo Pharmaceuticals Co. President Yasuo Okamoto shake hands at a press conference in Tokyo on Nov. 25. The two companies said they have reached a basic agreement to merge Oct. 1, 2005, creating a top-10 pharmaceutical maker in Japan in terms of prescription drug sales.

E

Taisho, Tanabe drugmakers to merge next April

TOKYO, Japan - Akira Uehara (R), president of Japan's Taisho Pharmaceutical Co., and Toshio Tanaka, president of Tanabe Seiyaku Co., another Japanese drugmaker, shake hands during a news conference at a Tokyo hotel on Sept. 17. They announced an integration of their business operations next year in a bid to survive the intensifying race in the domestic pharmaceuticals market, the world's second largest.

E

Drugmakers urged to stop shipping antifebrile drug

TOKYO, Japan - Photo shows medicines containing phenacetin, an antifebrile drug and painkiller. Japan's heath ministry on April 19 asked 25 pharmaceutical companies to stop shipping such medicines, saying patients taking the drugs are at risk of developing renal damage or bladder cancer.

E

Drugmakers Dainippon, Sumitomo to merge in Oct. 2005

TOKYO, Japan - Dainippon Pharmaceutical Co. President Kenjiro Miyatake (L) and Sumitomo Pharmaceuticals Co. President Yasuo Okamoto shake hands at a press conference in Tokyo on Nov. 25. The two companies said they have reached a basic agreement to merge Oct. 1, 2005, creating a top-10 pharmaceutical maker in Japan in terms of prescription drug sales. (Kyodo)

E

Pharmacies, drugmakers take steps to better serve foreigners

Haruka Hirose, a pharmacist at Nozomi pharmacy in Tokyo's Koto Ward, on Sept. 5, 2017 shows a point-and-speak conversation notebook that she compiled for pharmacies to communicate with foreign customers. (Kyodo) ==Kyodo

E

State, drugmakers ordered to compensate over hepatitis C infecti

OSAKA, Japan - Plaintiffs enter the Osaka District Court on June 21 before the court ordered the state and drugmakers to pay a total 256 million yen in damages to nine out of 13 people who were infected with the hepatitis C virus after being treated with tainted blood products. (Kyodo)

E

State, drugmakers ordered to compensate over hepatitis C infecti

OSAKA, Japan - Tomoko Kuwata (L) and Seiko Takeda, plaintiffs in a damages suit, hold a press conference after the Osaka District Court ruled on June 21 that the state and drugmakers were responsible for nine out of 13 people who were infected with the hepatitis C virus after being treated with tainted blood products. The ordered them to pay a total 256 million yen in damages. (Kyodo)

E

State, drugmakers ordered to compensate over hepatitis C infecti

OSAKA, Japan - A man holds a ''victory banner' in front of the Osaka District Court on June 21 after the court ordered the state and drugmakers to pay a total 256 million yen in damages to nine out of 13 people who were infected with the hepatitis C virus after being treated with tainted blood products. (Kyodo)

E

Gov't again ordered to pay damages over hepatitis C virus infect

TOKYO, Japan - Plaintiffs and their supporters express their joy on March 23 after the Tokyo District Court joined two other district courts in ordering the government to pay damages to people infected with the hepatitis C virus after being treated with tainted blood products. Presiding Judge Atsuo Nagano, acting on a 1,353 million yen damages suit, ordered the state and three drugmakers to pay a total of 259 million yen to 13 out of the 21 plaintiffs. (Kyodo)

E

First settlement reached in hepatitis damages suits against stat

FUKUOKA, Japan - A total of 29 hepatitis C sufferers suing the state and drugmakers for damages settled suits with the state in Osaka and Fukuoka on Feb. 4, the first such settlement among a series of similar lawsuits filed by about 240 people nationwide since 2002. Photo shows plaintiffs smiling during a news conference the same day after the settlement of their suit at the Fukuoka High Court. (Kyodo)

E

Gov't, hepatitis C patients sign accord to end legal battle

TOKYO, Japan - Health, Labor and Welfare Minister Yoichi Masuzoe (L) bows before the representatives of the plaintiffs in hepatitis C damages lawsuits against the state and drugmakers, at the Health, Labor and Welfare Ministry in Tokyo on Jan. 15 after the two sides signed a basic accord to end the protracted legal battle. The agreement is based on a law enacted last week offering blanket relief to those who contracted the liver illness through contaminated blood products such as fibrinogen which were administered to stop bleeding. (Kyodo)

E

Gov't, hepatitis C patients sign accord to end legal battle

TOKYO, Japan - Health, Labor and Welfare Minister Yoichi Masuzoe (R) shakes hands with Michiko Yamaguchi, leader of the plaintiffs in hepatitis C damages lawsuits against the state and drugmakers, at the Health, Labor and Welfare Ministry in Tokyo on Jan. 15 after the two sides signed a basic accord to end the protracted legal battle. The agreement is based on a law enacted last week offering blanket relief to those who contracted the liver illness through contaminated blood products such as fibrinogen which were administered to stop bleeding. (Kyodo)

E

Drugmakers urged to stop shipping antifebrile drug

TOKYO, Japan - Photo shows medicines containing phenacetin, an antifebrile drug and painkiller. Japan's heath ministry on April 19 asked 25 pharmaceutical companies to stop shipping such medicines, saying patients taking the drugs are at risk of developing renal damage or bladder cancer.